Management of Perioperative Anxiety by the Cardiac Coherence Technique Coupled With a Hypnosis Session (COHEC)

Management of Perioperative Anxiety by the Fixed Rate Guided Breathing Technique (Cardiac Coherence) Coupled With a Hypnosis Session, as Part of the Improved Pre-habilitation After Surgery

the investigator proposes to use the cardiac coherence technique coupled with a hypnosis session to improve post-operative recovery.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The perioperative period is recognized as an anxiety-provoking period for patients. If for some patients, this anxiety is more or less manageable, for others, it is the major concern with regard to their intervention, fearing not to wake up, to remain in a coma. Consideration of this aspect is very important for patients who require surgery. It is also a concern for caregivers involved in the care of these patients, including anesthesiologists, surgeons and operating room staff.

For many years, pharmacological premedication, including benzodiazepines, has been the gold standard in the treatment of preoperative anxiety.

This systematic prescription is controversial in populations most exposed to side effects such as the elderly, patients with heart or respiratory diseases.

Surgery also seems to influence the impact of premedication. For example, abdominal surgery and breast surgery are associated with a higher risk of agitation upon awakening.

Mental preparation, based on simple explanations by the anaesthetist, is not enough to reduce patients' anxiety.

A recent study evaluated the perioperative experience of patients receiving or not receiving premedication. It shows that benzodiazepines are associated with cognitive impairment and delayed extubation in the elderly. In addition, it seems to have little effect on patient anxiety when compared to a placebo.

In this context of anxiety, an emotional regulation tool appears particularly relevant. Cardiac coherence" (CC) is a particular state of cardiac variability. This state is correlated with many physiological and psychological variables. It is possible to promote this state through different techniques. One of its practices, "fixed frequency guided breathing", seems relevant both in its principles and in its simplicity of implementation.

This specific respiratory mode permits to rebalance the sympathetic - parasympathetic balance of the autonomic nervous system and reveals a state of calm vigilance. This simple, well-coded respiratory psychophysiological practice is widely used in many applications, such as for the most caricatural ones, the management of difficult situations where stress is a central element such as decision-making among fighter pilots on mission, in national education to improve academic learning (especially among anxious students) and also more generally in stress and anxiety management.

This technique induces a refocusing of emotions by regulating the SNA and therefore a better regulation of the hormones involved in the emotional cascade.

This practice has several advantages:

  • it is psychophysiological (psychocorporeal) and widely described in the scientific literature in several indications
  • it is completely free of charge and immediately accessible to the patient, regardless of time and place
  • it can be used at other anxiety-inducing times (e.g., imaging or biopsy tests)
  • it allows total patient autonomy, offering self-management of anxiety and independence from the presence of a third party
  • it can approach a hypnotic model by focusing and absorbing what it can induce on breathing, and thus share some of its benefits
  • It does not have any adverse effects. The major difficulty of this technique is the adherence and regularity of the practice. The optimal effect is dependent on regular training.

To improve this adherence, an audio tape will be put online, read in a hypnotic tone, which will aim to explain respiratory physiology, the benefits of oxygenation on cells and metabolism; this will have the effect of understanding the interest and utility of this exercise and will contribute to induce a feeling of relaxation and well-being.

This study will be a study of feasibility about a program based on the cardiac coherence technique in a context of perioperative anxiety.

Study Type

Interventional

Enrollment (Actual)

53

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hérault
      • Montpellier, Hérault, France, 34298
        • Institut Régional du Cancer de Montpellier

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Age ≥ 18 years old
  2. Surgery for breast or gynaecological cancer requiring scheduled hospitalization for up to 3 days
  3. Signing of informed consent before any specific procedure in the study
  4. Patient affiliated to a social security system

Exclusion Criteria:

  1. Patients undergoing outpatient surgery for their cancer will not be included
  2. Natural bradycardia (50 beats per minute)
  3. Patient taking β-blockers, digoxin, flecaine, isoptin, cordarone, diltiazem
  4. Cardiac arrhythmias
  5. Severe heart failure with ventricular ejection fraction < 40%
  6. Uncontrolled chronic pain
  7. Patients whose medical or psychological conditions do not allow them to complete the study or sign the consent
  8. Patient does not understand the French language
  9. Deaf and/or dumb patient
  10. Adult patient under guardianship or curatorship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cardiac coherence

An initiation session to cardiac coherence will take place between D-10 and D-7 before the operation (during the anaesthesia consultation) in order to obtain a breathing rate of 6 cycles/min via a free application (Respirelax) with listening to an audio tape.

3 cardiac coherence sessions per day of 5 min (before meals) during the 7 days preceding the operation.

- The anaesthetic induction will be done with a session of cardiac coherence associated with listening to the audio tape.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of patients who have enrolled in the pre-habilitation program
Time Frame: 7 days
A patient will be considered to have optimally adhered to the program if she performs at least 2/3 of the proposed cardiac coherence sessions (that represents 67% of the total number of sessions), that is, at least 14 sessions over the 7 days preceding the surgery.
7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The preoperative anxiety score by using the Amsterdam Preoperative Anxiety and Information Scale (APAIS)
Time Frame: 7 days
The anxiety scale consists of six items, each of which could be scored from 1 to 5 with the end poles "not at all" (1) and "extremely" (5). The score of the anxiety scale is the sum of these four questions, with a scoring range from 6 to 30.
7 days
Patient's satisfaction with perioperative period by using "Evaluation of the Vecu of General Anesthesia" questionnaire (EVAN-G)
Time Frame: 48 hours
The validated EVAN-G questionnaire includes 26 questions whose results are grouped together to define 6 "dimensions": Attention Focus, Information, Privacy, Pain, Discomfort and Wait Times. From these scores, an overall satisfaction score is calculated (average of all scores). For each of the scores: the higher the score, the higher the satisfaction. For each dimension, scores were reduced on a scale from 0 to 100. The higher the score, the higher the perceived quality of the experience. The total score was the sum of the scores of the six dimensions reduced to 100.
48 hours
Measurement of the Postoperative Quality of Recovery (QoR)
Time Frame: 10 days
The quality of postoperative functional recovery will be assessed by the QoR-15 questionnaire, which assesses five dimensions of recovery (physical comfort ; emotional state ; physical independence ; physiological support ; and pain). Each item was rated on a ten-point Likert scale: none of the time, some of the time, usually, most of the time, and all the time. The total score on the QoR-15 ranges from 0 (poorest quality of recovery) to 150 (best quality of recovery).
10 days
Measurement of anxiety level by using a visual analogue scale
Time Frame: 7 days
It's a visual scale from 0 (no anxiety) to 100 (highest anxiety)
7 days
Measurement of wake-up quality by using a visual analogue scale
Time Frame: 1 day
It's a visual scale from 0 (best wake-up) to 100 (worst wake-up)
1 day
Measurement of post-operative pain by using a visual analogue scale
Time Frame: 1 day
It's a visual scale from 0 (no pain) to 100 (highest pain)
1 day
Measurement of post-operative fatigue by using a visual analogue scale
Time Frame: 1 day
It's a visual scale from 0 (no fatigue) to 100 (highest fatigue)
1 day
Measurement of comfort and satisfaction with care by using a visual analogue scale
Time Frame: 1 day
It's a visual scale from 0 (ideal care) to 100 worst care)
1 day
Number of patients taking anesthetic drugs at induction of anaesthesia
Time Frame: 1 day
1 day
Number of patients taking anesthetic drugs during the post-interventional monitoring
Time Frame: 1 day
1 day
Number of patients taking morphine in recovery room
Time Frame: 1 day
1 day
Number of patients taking setrons (nausea and vomiting medication)
Time Frame: 1 day
1 day
Rate of patients that consider continuing the program of cardiac coherence
Time Frame: 1 day
1 day
Rate of patients willing to recommend the technique
Time Frame: 1 day
1 day
Number of days of hospitalization
Time Frame: 1 month
1 month
Number of patients taking morphine in peroperative
Time Frame: 1 day
1 day
Measurement of pain at inclusion by using a visual analogue scale
Time Frame: 1 day
It's a visual scale from 0 (no pain) to 100 (highest pain)
1 day
The recruitment rate (proportion of patients consenting to participate in the study among eligible patients at the screening) and reasons for refusal.
Time Frame: 1 day
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Jibba AMRAOUI, MD, Institut Régional du Cancer de Montpellier

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 14, 2020

Primary Completion (Actual)

January 14, 2022

Study Completion (Actual)

January 14, 2022

Study Registration Dates

First Submitted

June 7, 2019

First Submitted That Met QC Criteria

June 7, 2019

First Posted (Actual)

June 11, 2019

Study Record Updates

Last Update Posted (Actual)

September 28, 2023

Last Update Submitted That Met QC Criteria

September 26, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • PROICM 2019-06 COH

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All data will be available after publication of the results in peer-reviewed revues, and in national and international meetings. It includes all disidentified participants' data, the study protocol, the statistical analysis plan, the clinical study report and the analytic code. The corresponding author will provide data and datasets generated and/or analyzed during the study upon reasonable request.

IPD Sharing Time Frame

Access to study data upon written detailed request sent to ICM after publication.

IPD Sharing Access Criteria

The data shared will be limited to that required for independent mandated verification of the published results, the applicant will need authorization from ICM for personal access, and data will only be transferred after signing of a data access agreement.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on Cardiac coherence

3
Subscribe